Levonorgestrel intrauterine system
Sponsors
University of Medicine and Dentistry of New Jersey, Women and Infants Hospital of Rhode Island, Assiut University, Oregon Health and Science University, Makerere Unversity
Conditions
Abnormal Uterine BleedingAbnormal Uterine Bleeding, Endometrial Hemostatic DysfunctionAbnormal Uterine Bleeding, Ovulatory DysfunctionAdenomyosisBleeding DisorderEndometrial CancerFertility-femaleHeavy Menstrual Bleeding
Phase 3
Phase 4
Comparison Between Levonorgestrel-Releasing Intrauterine System and Injectable Hormonal Therapy for Persistent Abnormal Uterine Bleeding Following Tubal Ligation
Active, not recruitingPACTR202608685167118
Start: 2026-09-01Target: 100Updated: 2026-09-14
Effects of Copper versus levonorgestrel intrauterine devices on mucosal microbiota and barrier function: a randomized trial among young African women
RecruitingPACTR202608613115417
Start: 2026-06-01Target: 120Updated: 2026-09-14
Unknown Phase
A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35
TerminatedNCT00161226
Start: 2004-02-29End: 2006-06-30Target: 44Updated: 2009-12-11
Stopping Heavy Periods Project
NCT02002260
Start: 2013-02-28End: 2021-12-31Target: 59Updated: 2021-08-02
Levonorgestrel Intrauterine System and Adenomyosis
CompletedNCT03104309
Start: 2015-06-30End: 2016-08-31Updated: 2017-04-14
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
RecruitingNCT05916469
Start: 2025-09-24End: 2029-06-30Target: 300Updated: 2025-12-17